Knowledge and Level of Use of Misoprostol by Health Care Providers in the Maternity Wards of South Kivu in the Practice of Obstetrics  

作　　者：De-Joseph Kakisingi Mibi Julien Bwama Botalatala Gloire Mubake Wabulakombe Dieudonné Kakusu Marie Constance Nguru Musese Omari Mukanga Luc Kalala Moïse Kiminyi Émile Mapatano Shalamba Mukanire Ntakwindja Olivier Nyakio De-Joseph Kakisingi Mibi;Julien Bwama Botalatala;Gloire Mubake Wabulakombe;Dieudonné Kakusu;Marie Constance Nguru Musese;Omari Mukanga;Luc Kalala;Moïse Kiminyi;Émile Mapatano Shalamba;Mukanire Ntakwindja;Olivier Nyakio(Department of Gynecology and Obstetrics, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo;Departement of Medicine and Public Health, Evangelical University in Africa, Bukavu, Democratic Republic of the Congo;Saint Vincent Hospital, Bukavu, Democratic Republic of the Congo;Department of Statistics, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo)

机构地区：[1]Department of Gynecology and Obstetrics, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo [2]Departement of Medicine and Public Health, Evangelical University in Africa, Bukavu, Democratic Republic of the Congo [3]Saint Vincent Hospital, Bukavu, Democratic Republic of the Congo [4]Department of Statistics, Panzi General Referral Hospital, Bukavu, Democratic Republic of the Congo

出　　处：《Open Journal of Obstetrics and Gynecology》2023年第7期1234-1243,共10页妇产科期刊（英文）

摘　　要：Post-partum haemorrhage (PPH) is one of the leading causes of maternal death in sub-Saharan Africa. In developing countries, PPH is responsible for about 30% of maternal deaths. The main causes of PPH are uterine atony, placental implantation anomalies and coagulation disorders. Acting on the causes of post-partum haemorrhage would significantly reduce maternal mortality. To prevent PPH, the World Health Organization (WHO) recommends the use of uterotonics as a preventive measure. Although parenteral Oxytocin is recommended as the first line Oxytocic for the prevention of PPH, the use of misoprostol is increasingly used in gynaecology and obstetrics, not only for the prevention of postpartum haemorrhage, but also for many other obstetric indications. The aim of this study was to assess the knowledge and level of use of misoprostol by healthcare providers in the gynaecology and maternity departments of South Kivu in the practice of gynaecology and obstetrics. Materials and methods We conducted a descriptive study from January 03 up to February 04, 2023. The study of population was made up of healthcare workers in South Kivu. A questionnaire containing questions relating to socio-demographic informations and knowledge of misoprostol was prepared and encoded in the kobo collect software. To access the questionnaire, it was compulsory to read the research protocol and give consent by ticking the “yes” button. All those who ticked “no” were denied access to the questionnaire. The link was sent, with a request to take part in the survey, to groups in the social networks of doctors and midwives in South Kivu. For areas not covered by the internet, a printed format was distributed and then encoded by data entry operators. For the paper format, respondents were also asked to indicate their consent by ticking the “yes” box. All the encoded data was automatically compiled on the server and then analysed and interpreted by the research team. Results: Nearly all (95.8%) healthcare workers in South Kivu knew about Post-partum haemorrhage (PPH) is one of the leading causes of maternal death in sub-Saharan Africa. In developing countries, PPH is responsible for about 30% of maternal deaths. The main causes of PPH are uterine atony, placental implantation anomalies and coagulation disorders. Acting on the causes of post-partum haemorrhage would significantly reduce maternal mortality. To prevent PPH, the World Health Organization (WHO) recommends the use of uterotonics as a preventive measure. Although parenteral Oxytocin is recommended as the first line Oxytocic for the prevention of PPH, the use of misoprostol is increasingly used in gynaecology and obstetrics, not only for the prevention of postpartum haemorrhage, but also for many other obstetric indications. The aim of this study was to assess the knowledge and level of use of misoprostol by healthcare providers in the gynaecology and maternity departments of South Kivu in the practice of gynaecology and obstetrics. Materials and methods We conducted a descriptive study from January 03 up to February 04, 2023. The study of population was made up of healthcare workers in South Kivu. A questionnaire containing questions relating to socio-demographic informations and knowledge of misoprostol was prepared and encoded in the kobo collect software. To access the questionnaire, it was compulsory to read the research protocol and give consent by ticking the “yes” button. All those who ticked “no” were denied access to the questionnaire. The link was sent, with a request to take part in the survey, to groups in the social networks of doctors and midwives in South Kivu. For areas not covered by the internet, a printed format was distributed and then encoded by data entry operators. For the paper format, respondents were also asked to indicate their consent by ticking the “yes” box. All the encoded data was automatically compiled on the server and then analysed and interpreted by the research team. Results: Nearly all (95.8%) healthcare workers in South Kivu knew about

关 键 词：MISOPROSTOL Postpartum Haemorrhage UTEROTONIC 

分 类 号：R16[医药卫生—公共卫生与预防医学]